CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
Sara Onali 1
Amalia Di Petrillo
Agnese Favale
Claudia Carpineti
Marta Cadoni
Erica Loddo
Massimo Claudio Fantini
1 University of Cagliari, Monserrato (CA), Italy
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]